The global Human Rabies Immunoglobulin (IM) market size was valued at USD 407.5 million in 2022 and is forecast to a readjusted size of USD 610 million by 2029 with a CAGR of 5.9% during review period.
Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.
Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient's passive immunization.
Global Human Rabies Immunoglobulin (IM) key players include CSL Behring, Grifols, Sanofi, etc. Global top three manufacturers hold a share about 60%. North America is the largest market, with a share over 30%, followed by China and Europe, both have a share about 45 percent. In terms of product, HRIG is the largest segment, with a share over 85%. And in terms of application, the largest application is Category III Exposure, followed by Category II Exposure.
This report is a detailed and comprehensive analysis for global Human Rabies Immunoglobulin (IM) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Human Rabies Immunoglobulin (IM) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Human Rabies Immunoglobulin (IM) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Human Rabies Immunoglobulin (IM) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Human Rabies Immunoglobulin (IM) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Rabies Immunoglobulin (IM)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Rabies Immunoglobulin (IM) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
CSL Behring
Grifols
Sanofi
Sichuan Yuanda Shuyang
CNBG
Kamada
CBPO
Shuanglin Bio
Weiguang Bio
Shanghai RAAS
Bharat Serum
VINS
ERIG
HRIG
Category II Exposure
Category III Exposure
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Human Rabies Immunoglobulin (IM) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Rabies Immunoglobulin (IM), with price, sales, revenue and global market share of Human Rabies Immunoglobulin (IM) from 2018 to 2023.
Chapter 3, the Human Rabies Immunoglobulin (IM) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Rabies Immunoglobulin (IM) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Human Rabies Immunoglobulin (IM) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Rabies Immunoglobulin (IM).
Chapter 14 and 15, to describe Human Rabies Immunoglobulin (IM) sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Human Rabies Immunoglobulin (IM)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Human Rabies Immunoglobulin (IM) Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 ERIG
1.3.3 HRIG
1.4 Market Analysis by Application
1.4.1 Overview: Global Human Rabies Immunoglobulin (IM) Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Category II Exposure
1.4.3 Category III Exposure
1.5 Global Human Rabies Immunoglobulin (IM) Market Size & Forecast
1.5.1 Global Human Rabies Immunoglobulin (IM) Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Human Rabies Immunoglobulin (IM) Sales Quantity (2018-2029)
1.5.3 Global Human Rabies Immunoglobulin (IM) Average Price (2018-2029)
2 Manufacturers Profiles
2.1 CSL Behring
2.1.1 CSL Behring Details
2.1.2 CSL Behring Major Business
2.1.3 CSL Behring Human Rabies Immunoglobulin (IM) Product and Services
2.1.4 CSL Behring Human Rabies Immunoglobulin (IM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 CSL Behring Recent Developments/Updates
2.2 Grifols
2.2.1 Grifols Details
2.2.2 Grifols Major Business
2.2.3 Grifols Human Rabies Immunoglobulin (IM) Product and Services
2.2.4 Grifols Human Rabies Immunoglobulin (IM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Grifols Recent Developments/Updates
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Human Rabies Immunoglobulin (IM) Product and Services
2.3.4 Sanofi Human Rabies Immunoglobulin (IM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sanofi Recent Developments/Updates
2.4 Sichuan Yuanda Shuyang
2.4.1 Sichuan Yuanda Shuyang Details
2.4.2 Sichuan Yuanda Shuyang Major Business
2.4.3 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product and Services
2.4.4 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Sichuan Yuanda Shuyang Recent Developments/Updates
2.5 CNBG
2.5.1 CNBG Details
2.5.2 CNBG Major Business
2.5.3 CNBG Human Rabies Immunoglobulin (IM) Product and Services
2.5.4 CNBG Human Rabies Immunoglobulin (IM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 CNBG Recent Developments/Updates
2.6 Kamada
2.6.1 Kamada Details
2.6.2 Kamada Major Business
2.6.3 Kamada Human Rabies Immunoglobulin (IM) Product and Services
2.6.4 Kamada Human Rabies Immunoglobulin (IM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Kamada Recent Developments/Updates
2.7 CBPO
2.7.1 CBPO Details
2.7.2 CBPO Major Business
2.7.3 CBPO Human Rabies Immunoglobulin (IM) Product and Services
2.7.4 CBPO Human Rabies Immunoglobulin (IM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 CBPO Recent Developments/Updates
2.8 Shuanglin Bio
2.8.1 Shuanglin Bio Details
2.8.2 Shuanglin Bio Major Business
2.8.3 Shuanglin Bio Human Rabies Immunoglobulin (IM) Product and Services
2.8.4 Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Shuanglin Bio Recent Developments/Updates
2.9 Weiguang Bio
2.9.1 Weiguang Bio Details
2.9.2 Weiguang Bio Major Business
2.9.3 Weiguang Bio Human Rabies Immunoglobulin (IM) Product and Services
2.9.4 Weiguang Bio Human Rabies Immunoglobulin (IM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Weiguang Bio Recent Developments/Updates
2.10 Shanghai RAAS
2.10.1 Shanghai RAAS Details
2.10.2 Shanghai RAAS Major Business
2.10.3 Shanghai RAAS Human Rabies Immunoglobulin (IM) Product and Services
2.10.4 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Shanghai RAAS Recent Developments/Updates
2.11 Bharat Serum
2.11.1 Bharat Serum Details
2.11.2 Bharat Serum Major Business
2.11.3 Bharat Serum Human Rabies Immunoglobulin (IM) Product and Services
2.11.4 Bharat Serum Human Rabies Immunoglobulin (IM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Bharat Serum Recent Developments/Updates
2.12 VINS
2.12.1 VINS Details
2.12.2 VINS Major Business
2.12.3 VINS Human Rabies Immunoglobulin (IM) Product and Services
2.12.4 VINS Human Rabies Immunoglobulin (IM) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 VINS Recent Developments/Updates
3 Competitive Environment: Human Rabies Immunoglobulin (IM) by Manufacturer
3.1 Global Human Rabies Immunoglobulin (IM) Sales Quantity by Manufacturer (2018-2023)
3.2 Global Human Rabies Immunoglobulin (IM) Revenue by Manufacturer (2018-2023)
3.3 Global Human Rabies Immunoglobulin (IM) Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Human Rabies Immunoglobulin (IM) by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Human Rabies Immunoglobulin (IM) Manufacturer Market Share in 2022
3.4.2 Top 6 Human Rabies Immunoglobulin (IM) Manufacturer Market Share in 2022
3.5 Human Rabies Immunoglobulin (IM) Market: Overall Company Footprint Analysis
3.5.1 Human Rabies Immunoglobulin (IM) Market: Region Footprint
3.5.2 Human Rabies Immunoglobulin (IM) Market: Company Product Type Footprint
3.5.3 Human Rabies Immunoglobulin (IM) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Human Rabies Immunoglobulin (IM) Market Size by Region
4.1.1 Global Human Rabies Immunoglobulin (IM) Sales Quantity by Region (2018-2029)
4.1.2 Global Human Rabies Immunoglobulin (IM) Consumption Value by Region (2018-2029)
4.1.3 Global Human Rabies Immunoglobulin (IM) Average Price by Region (2018-2029)
4.2 North America Human Rabies Immunoglobulin (IM) Consumption Value (2018-2029)
4.3 Europe Human Rabies Immunoglobulin (IM) Consumption Value (2018-2029)
4.4 Asia-Pacific Human Rabies Immunoglobulin (IM) Consumption Value (2018-2029)
4.5 South America Human Rabies Immunoglobulin (IM) Consumption Value (2018-2029)
4.6 Middle East and Africa Human Rabies Immunoglobulin (IM) Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Human Rabies Immunoglobulin (IM) Sales Quantity by Type (2018-2029)
5.2 Global Human Rabies Immunoglobulin (IM) Consumption Value by Type (2018-2029)
5.3 Global Human Rabies Immunoglobulin (IM) Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Human Rabies Immunoglobulin (IM) Sales Quantity by Application (2018-2029)
6.2 Global Human Rabies Immunoglobulin (IM) Consumption Value by Application (2018-2029)
6.3 Global Human Rabies Immunoglobulin (IM) Average Price by Application (2018-2029)
7 North America
7.1 North America Human Rabies Immunoglobulin (IM) Sales Quantity by Type (2018-2029)
7.2 North America Human Rabies Immunoglobulin (IM) Sales Quantity by Application (2018-2029)
7.3 North America Human Rabies Immunoglobulin (IM) Market Size by Country
7.3.1 North America Human Rabies Immunoglobulin (IM) Sales Quantity by Country (2018-2029)
7.3.2 North America Human Rabies Immunoglobulin (IM) Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Human Rabies Immunoglobulin (IM) Sales Quantity by Type (2018-2029)
8.2 Europe Human Rabies Immunoglobulin (IM) Sales Quantity by Application (2018-2029)
8.3 Europe Human Rabies Immunoglobulin (IM) Market Size by Country
8.3.1 Europe Human Rabies Immunoglobulin (IM) Sales Quantity by Country (2018-2029)
8.3.2 Europe Human Rabies Immunoglobulin (IM) Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Human Rabies Immunoglobulin (IM) Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Human Rabies Immunoglobulin (IM) Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Human Rabies Immunoglobulin (IM) Market Size by Region
9.3.1 Asia-Pacific Human Rabies Immunoglobulin (IM) Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Human Rabies Immunoglobulin (IM) Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Human Rabies Immunoglobulin (IM) Sales Quantity by Type (2018-2029)
10.2 South America Human Rabies Immunoglobulin (IM) Sales Quantity by Application (2018-2029)
10.3 South America Human Rabies Immunoglobulin (IM) Market Size by Country
10.3.1 South America Human Rabies Immunoglobulin (IM) Sales Quantity by Country (2018-2029)
10.3.2 South America Human Rabies Immunoglobulin (IM) Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Human Rabies Immunoglobulin (IM) Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Human Rabies Immunoglobulin (IM) Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Human Rabies Immunoglobulin (IM) Market Size by Country
11.3.1 Middle East & Africa Human Rabies Immunoglobulin (IM) Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Human Rabies Immunoglobulin (IM) Market Drivers
12.2 Human Rabies Immunoglobulin (IM) Market Restraints
12.3 Human Rabies Immunoglobulin (IM) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Human Rabies Immunoglobulin (IM) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Human Rabies Immunoglobulin (IM)
13.3 Human Rabies Immunoglobulin (IM) Production Process
13.4 Human Rabies Immunoglobulin (IM) Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Human Rabies Immunoglobulin (IM) Typical Distributors
14.3 Human Rabies Immunoglobulin (IM) Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Human Rabies Immunoglobulin (IM) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Human Rabies Immunoglobulin (IM) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 4. CSL Behring Major Business
Table 5. CSL Behring Human Rabies Immunoglobulin (IM) Product and Services
Table 6. CSL Behring Human Rabies Immunoglobulin (IM) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. CSL Behring Recent Developments/Updates
Table 8. Grifols Basic Information, Manufacturing Base and Competitors
Table 9. Grifols Major Business
Table 10. Grifols Human Rabies Immunoglobulin (IM) Product and Services
Table 11. Grifols Human Rabies Immunoglobulin (IM) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Grifols Recent Developments/Updates
Table 13. Sanofi Basic Information, Manufacturing Base and Competitors
Table 14. Sanofi Major Business
Table 15. Sanofi Human Rabies Immunoglobulin (IM) Product and Services
Table 16. Sanofi Human Rabies Immunoglobulin (IM) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Sanofi Recent Developments/Updates
Table 18. Sichuan Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
Table 19. Sichuan Yuanda Shuyang Major Business
Table 20. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product and Services
Table 21. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Sichuan Yuanda Shuyang Recent Developments/Updates
Table 23. CNBG Basic Information, Manufacturing Base and Competitors
Table 24. CNBG Major Business
Table 25. CNBG Human Rabies Immunoglobulin (IM) Product and Services
Table 26. CNBG Human Rabies Immunoglobulin (IM) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. CNBG Recent Developments/Updates
Table 28. Kamada Basic Information, Manufacturing Base and Competitors
Table 29. Kamada Major Business
Table 30. Kamada Human Rabies Immunoglobulin (IM) Product and Services
Table 31. Kamada Human Rabies Immunoglobulin (IM) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Kamada Recent Developments/Updates
Table 33. CBPO Basic Information, Manufacturing Base and Competitors
Table 34. CBPO Major Business
Table 35. CBPO Human Rabies Immunoglobulin (IM) Product and Services
Table 36. CBPO Human Rabies Immunoglobulin (IM) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. CBPO Recent Developments/Updates
Table 38. Shuanglin Bio Basic Information, Manufacturing Base and Competitors
Table 39. Shuanglin Bio Major Business
Table 40. Shuanglin Bio Human Rabies Immunoglobulin (IM) Product and Services
Table 41. Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Shuanglin Bio Recent Developments/Updates
Table 43. Weiguang Bio Basic Information, Manufacturing Base and Competitors
Table 44. Weiguang Bio Major Business
Table 45. Weiguang Bio Human Rabies Immunoglobulin (IM) Product and Services
Table 46. Weiguang Bio Human Rabies Immunoglobulin (IM) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Weiguang Bio Recent Developments/Updates
Table 48. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
Table 49. Shanghai RAAS Major Business
Table 50. Shanghai RAAS Human Rabies Immunoglobulin (IM) Product and Services
Table 51. Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Shanghai RAAS Recent Developments/Updates
Table 53. Bharat Serum Basic Information, Manufacturing Base and Competitors
Table 54. Bharat Serum Major Business
Table 55. Bharat Serum Human Rabies Immunoglobulin (IM) Product and Services
Table 56. Bharat Serum Human Rabies Immunoglobulin (IM) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Bharat Serum Recent Developments/Updates
Table 58. VINS Basic Information, Manufacturing Base and Competitors
Table 59. VINS Major Business
Table 60. VINS Human Rabies Immunoglobulin (IM) Product and Services
Table 61. VINS Human Rabies Immunoglobulin (IM) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. VINS Recent Developments/Updates
Table 63. Global Human Rabies Immunoglobulin (IM) Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 64. Global Human Rabies Immunoglobulin (IM) Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Human Rabies Immunoglobulin (IM) Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 66. Market Position of Manufacturers in Human Rabies Immunoglobulin (IM), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Human Rabies Immunoglobulin (IM) Production Site of Key Manufacturer
Table 68. Human Rabies Immunoglobulin (IM) Market: Company Product Type Footprint
Table 69. Human Rabies Immunoglobulin (IM) Market: Company Product Application Footprint
Table 70. Human Rabies Immunoglobulin (IM) New Market Entrants and Barriers to Market Entry
Table 71. Human Rabies Immunoglobulin (IM) Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Human Rabies Immunoglobulin (IM) Sales Quantity by Region (2018-2023) & (K Units)
Table 73. Global Human Rabies Immunoglobulin (IM) Sales Quantity by Region (2024-2029) & (K Units)
Table 74. Global Human Rabies Immunoglobulin (IM) Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Human Rabies Immunoglobulin (IM) Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Human Rabies Immunoglobulin (IM) Average Price by Region (2018-2023) & (USD/Unit)
Table 77. Global Human Rabies Immunoglobulin (IM) Average Price by Region (2024-2029) & (USD/Unit)
Table 78. Global Human Rabies Immunoglobulin (IM) Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Global Human Rabies Immunoglobulin (IM) Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Global Human Rabies Immunoglobulin (IM) Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Human Rabies Immunoglobulin (IM) Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Human Rabies Immunoglobulin (IM) Average Price by Type (2018-2023) & (USD/Unit)
Table 83. Global Human Rabies Immunoglobulin (IM) Average Price by Type (2024-2029) & (USD/Unit)
Table 84. Global Human Rabies Immunoglobulin (IM) Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Global Human Rabies Immunoglobulin (IM) Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Global Human Rabies Immunoglobulin (IM) Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Human Rabies Immunoglobulin (IM) Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Human Rabies Immunoglobulin (IM) Average Price by Application (2018-2023) & (USD/Unit)
Table 89. Global Human Rabies Immunoglobulin (IM) Average Price by Application (2024-2029) & (USD/Unit)
Table 90. North America Human Rabies Immunoglobulin (IM) Sales Quantity by Type (2018-2023) & (K Units)
Table 91. North America Human Rabies Immunoglobulin (IM) Sales Quantity by Type (2024-2029) & (K Units)
Table 92. North America Human Rabies Immunoglobulin (IM) Sales Quantity by Application (2018-2023) & (K Units)
Table 93. North America Human Rabies Immunoglobulin (IM) Sales Quantity by Application (2024-2029) & (K Units)
Table 94. North America Human Rabies Immunoglobulin (IM) Sales Quantity by Country (2018-2023) & (K Units)
Table 95. North America Human Rabies Immunoglobulin (IM) Sales Quantity by Country (2024-2029) & (K Units)
Table 96. North America Human Rabies Immunoglobulin (IM) Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Human Rabies Immunoglobulin (IM) Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Human Rabies Immunoglobulin (IM) Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Europe Human Rabies Immunoglobulin (IM) Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Europe Human Rabies Immunoglobulin (IM) Sales Quantity by Application (2018-2023) & (K Units)
Table 101. Europe Human Rabies Immunoglobulin (IM) Sales Quantity by Application (2024-2029) & (K Units)
Table 102. Europe Human Rabies Immunoglobulin (IM) Sales Quantity by Country (2018-2023) & (K Units)
Table 103. Europe Human Rabies Immunoglobulin (IM) Sales Quantity by Country (2024-2029) & (K Units)
Table 104. Europe Human Rabies Immunoglobulin (IM) Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Human Rabies Immunoglobulin (IM) Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Human Rabies Immunoglobulin (IM) Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Asia-Pacific Human Rabies Immunoglobulin (IM) Sales Quantity by Type (2024-2029) & (K Units)
Table 108. Asia-Pacific Human Rabies Immunoglobulin (IM) Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Asia-Pacific Human Rabies Immunoglobulin (IM) Sales Quantity by Application (2024-2029) & (K Units)
Table 110. Asia-Pacific Human Rabies Immunoglobulin (IM) Sales Quantity by Region (2018-2023) & (K Units)
Table 111. Asia-Pacific Human Rabies Immunoglobulin (IM) Sales Quantity by Region (2024-2029) & (K Units)
Table 112. Asia-Pacific Human Rabies Immunoglobulin (IM) Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Human Rabies Immunoglobulin (IM) Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Human Rabies Immunoglobulin (IM) Sales Quantity by Type (2018-2023) & (K Units)
Table 115. South America Human Rabies Immunoglobulin (IM) Sales Quantity by Type (2024-2029) & (K Units)
Table 116. South America Human Rabies Immunoglobulin (IM) Sales Quantity by Application (2018-2023) & (K Units)
Table 117. South America Human Rabies Immunoglobulin (IM) Sales Quantity by Application (2024-2029) & (K Units)
Table 118. South America Human Rabies Immunoglobulin (IM) Sales Quantity by Country (2018-2023) & (K Units)
Table 119. South America Human Rabies Immunoglobulin (IM) Sales Quantity by Country (2024-2029) & (K Units)
Table 120. South America Human Rabies Immunoglobulin (IM) Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Human Rabies Immunoglobulin (IM) Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales Quantity by Type (2018-2023) & (K Units)
Table 123. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales Quantity by Type (2024-2029) & (K Units)
Table 124. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales Quantity by Region (2018-2023) & (K Units)
Table 127. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales Quantity by Region (2024-2029) & (K Units)
Table 128. Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Human Rabies Immunoglobulin (IM) Raw Material
Table 131. Key Manufacturers of Human Rabies Immunoglobulin (IM) Raw Materials
Table 132. Human Rabies Immunoglobulin (IM) Typical Distributors
Table 133. Human Rabies Immunoglobulin (IM) Typical Customers
List of Figures
Figure 1. Human Rabies Immunoglobulin (IM) Picture
Figure 2. Global Human Rabies Immunoglobulin (IM) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Human Rabies Immunoglobulin (IM) Consumption Value Market Share by Type in 2022
Figure 4. ERIG Examples
Figure 5. HRIG Examples
Figure 6. Global Human Rabies Immunoglobulin (IM) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Human Rabies Immunoglobulin (IM) Consumption Value Market Share by Application in 2022
Figure 8. Category II Exposure Examples
Figure 9. Category III Exposure Examples
Figure 10. Global Human Rabies Immunoglobulin (IM) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Human Rabies Immunoglobulin (IM) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Human Rabies Immunoglobulin (IM) Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Human Rabies Immunoglobulin (IM) Average Price (2018-2029) & (USD/Unit)
Figure 14. Global Human Rabies Immunoglobulin (IM) Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Human Rabies Immunoglobulin (IM) Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Human Rabies Immunoglobulin (IM) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Human Rabies Immunoglobulin (IM) Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Human Rabies Immunoglobulin (IM) Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Human Rabies Immunoglobulin (IM) Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Human Rabies Immunoglobulin (IM) Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Human Rabies Immunoglobulin (IM) Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Human Rabies Immunoglobulin (IM) Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Human Rabies Immunoglobulin (IM) Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Human Rabies Immunoglobulin (IM) Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Human Rabies Immunoglobulin (IM) Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Human Rabies Immunoglobulin (IM) Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Human Rabies Immunoglobulin (IM) Average Price by Type (2018-2029) & (USD/Unit)
Figure 29. Global Human Rabies Immunoglobulin (IM) Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Human Rabies Immunoglobulin (IM) Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Human Rabies Immunoglobulin (IM) Average Price by Application (2018-2029) & (USD/Unit)
Figure 32. North America Human Rabies Immunoglobulin (IM) Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Human Rabies Immunoglobulin (IM) Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Human Rabies Immunoglobulin (IM) Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Human Rabies Immunoglobulin (IM) Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Human Rabies Immunoglobulin (IM) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Human Rabies Immunoglobulin (IM) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Human Rabies Immunoglobulin (IM) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Human Rabies Immunoglobulin (IM) Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Human Rabies Immunoglobulin (IM) Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Human Rabies Immunoglobulin (IM) Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Human Rabies Immunoglobulin (IM) Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Human Rabies Immunoglobulin (IM) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Human Rabies Immunoglobulin (IM) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Human Rabies Immunoglobulin (IM) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Human Rabies Immunoglobulin (IM) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Human Rabies Immunoglobulin (IM) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Human Rabies Immunoglobulin (IM) Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Human Rabies Immunoglobulin (IM) Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Human Rabies Immunoglobulin (IM) Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Human Rabies Immunoglobulin (IM) Consumption Value Market Share by Region (2018-2029)
Figure 52. China Human Rabies Immunoglobulin (IM) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Human Rabies Immunoglobulin (IM) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Human Rabies Immunoglobulin (IM) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Human Rabies Immunoglobulin (IM) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Human Rabies Immunoglobulin (IM) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Human Rabies Immunoglobulin (IM) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Human Rabies Immunoglobulin (IM) Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Human Rabies Immunoglobulin (IM) Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Human Rabies Immunoglobulin (IM) Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Human Rabies Immunoglobulin (IM) Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Human Rabies Immunoglobulin (IM) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Human Rabies Immunoglobulin (IM) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Human Rabies Immunoglobulin (IM) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Human Rabies Immunoglobulin (IM) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Human Rabies Immunoglobulin (IM) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Human Rabies Immunoglobulin (IM) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Human Rabies Immunoglobulin (IM) Market Drivers
Figure 73. Human Rabies Immunoglobulin (IM) Market Restraints
Figure 74. Human Rabies Immunoglobulin (IM) Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Human Rabies Immunoglobulin (IM) in 2022
Figure 77. Manufacturing Process Analysis of Human Rabies Immunoglobulin (IM)
Figure 78. Human Rabies Immunoglobulin (IM) Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
